[Truncated abstract] In order to expand the gene pool of canola-quality rapeseed (Brassica napus) reciprocal interspecific crosses were made between B. napus cv. Mystic and near canola-quality B. juncea breeding line JN29. F1 progeny from these crosses were used to make backcrosses to both parents in all possible combinations and directions, and were selfed to form F2-derived lines. The highest frequencies of viable F2 and BC1 progeny were obtained when B. napus was the maternal parent of the interspecific hybrid. BC1 and F2 progeny (and subsequent generations) were grown under field conditions to identify agronomic improvements over the parents. Transgressive segregation was observed in F2 and BC1 and in subsequent generations for agronomic traits (seed yield under high or low rainfall conditions, plant biomass, harvest index, height, branching and days to anthesis) and seed quality traits (oil, protein, glucosinolates, oleic acid). The majority of progeny conformed to B. napus morphology, and a minority segregated to B. juncea morphology in subsequent generations. Some of the B. juncea morphotypes had lower glucosinolates and higher oleic acid than the parent JN29, with no detectable erucic acid, and thereby conformed to canola quality. Methods were developed for tracing B-genome in interspecific progeny. A repetitive DNA sequence pBNBH35 from B. nigra (genome BB, 2n = 16) was used to identify B-genome chromosomes and introgressions in interspecific progeny. Specific primers were designed for pBNBH35 in order to amplify the repetitive sequence by PCR. A cloned sub-fragment of 329 bp was confirmed by sequencing as part of pBNBH35. PCR and hybridisation techniques were used on an array of Brassica species to confirm that the pBNBH35 subfragment was Brassica B-genome specific. Fluorescence in situ hybridisation (FISH) in B nigra, B. juncea (AABB, 2n=36) and B. napus (AACC, 2n=38) showed that the pBNBH35 sub-fragment was present on all eight Brassica Bgenome chromosomes and absent from A- and C-genome chromosomes. The pBNBH35 repeat was localised to the centromeric region of each B-genome chromosome. FISH clearly distinguished the B-genome chromosomes from the A-genome chromosomes in the amphidiploid species B. juncea. This is the first known report of a B-genome repetitive marker that is present on all Brassica Bgenome chromosomes. ... The results suggest that novel B. napus genotypes have been generated containing introgressions of B-genome chromatin from B. juncea chromosomes. B. juncea morphology occurred in interspecific progeny with a chromosome complement similar to B. napus (2n = 38) and without the entire Bgenome present. It also is highly likely that recombination has occurred between the A-genome of the two Brassica species. This research has demonstrated that the secondary gene pool of B. napus may be accessed by selfing interspecific hybrids, and without sacrificing canola quality, if the B. juncea parent is near canola-quality. Interspecific progeny may be screened to enhance the proportion with B-genome positive signals. Some progeny with B. junceatype morphology had improved seed quality over the JN29 parent.

Despite significant advances in diagnosis and treatment, breast cancer remains the leading cause of cancer-related deaths in Australian women. Colorectal cancer is the second most common cancer in both males and females; after prostate and breast cancer, respectively, and excluding non-melanocytic skin cancer. Both breast cancer and colorectal cancer follow a common progressive course of illness; presenting (at least initially) with benign symptoms that can be treated by ablation (or removal) of the affected area. Cancer progression is associated with breakdown of tissue barriers (such as basement membranes), leading to the spread of cancer cells (via the vasculature or lymphatic system), and the establishment of secondary metastatic disease at green-field sites. Secondary tumours presenting in the lungs, ovaries, liver, bone, or brain are associated with chronic-debilitating symptoms that are difficult to treat, and will result in death. In the case of breast and colon cancer, effective early therapeutic intervention does have a significant impact upon patient survival. Tumour progression in breast and colon carcinomas is characterised by invasion of the surrounding stroma, and the acquisition of stromal characteristics, by previously epithelial cells. This progression is associated with the expression of extracellular proteases (ECPs) and increased motility. The process of mesenchymal transformation that tumour cells undergo is also referred to as the epithelial to mesenchymal transition (EMT). In general terms the aim of the study, presented in this thesis, was to investigate gene expression in cancer biology; and to characterise changes in breast cancer and colon cancer, with a focus on those genes, and gene products that may play a role in metastasis, including a family of ECPs, the matrix metalloproteinases (MMPs). In our laboratory, we have applied methods in microdissection, differential display polymerase chain reaction amplification (DD-PCR), and array hybridisation analysis to identify gene expression patterns in late stage archival formalin fixed paraffin embedded (FFPE) breast tumour biopsies that may be indicative of the EMT; or the response to the surrounding stroma/interstitium to the presence of the tumour.' The quality of nucleic acid obtainable from FFPE material presents a considerable challenge for gene expression studies. In order to identify tissue specific gene expression patterns, DD-PCR products, amplified from message obtained following segregation of tumour tissue from surrounding stroma, was hybridised to arrayed cDNA libraries created from stromal tumours, or sarcomas. In this way, 21 known genes, or expressed sequence tags (ESTs), were identified. These included the cytoskeletal element and EMT marker, vimentin, the mammary developmental factor and, signal transducer and activator of transcription (STAT)-3, and the cargo selection protein (TIP47). Seventeen genes showed differential expression in either the tumour, or stromal fractions. When applied to transformed breast cancer cell lines (MDA-MB-435 & T47D) DD-array analysis revealed a further 17 genes that were differentially regulated in invasive cells, compared with those displaying a less invasive phenotype. Six of the ESTs identified by DD-PCR array analysis, had no known (or predicted) function. For example, bcaf-2 was identified as the 3'-end of a putative open reading frame (ORF) localised to chromosome 6, while bcaf-10 showed homology with a known ORF. In order to analyse the expression of these bcafs further, a stromal cell culture model, representative of the original osteosarcoma cDNA libraries from which they were obtained, was used. In this model, CD14' (or adherent) peripheral blood mononuclear cells (PBMCs) treated with macrophage colony stimulating factor (M-CSF), can be allowed to differentiate into macrophage-like (ML) cells; while cells treated with M-CSF, and the receptor activator of NF-KB ligand (RANKL) will differentiate into multinucleate osteoclast-like (OCL) multinucleate giant cells. Uniquely, the stromal EST, bcaf-2 was expressed only by RANKL-treated (or OCL) cells. bcaf-2 and other ESTs, identified by DD-PCR analysis (and recently published) are the subject of on going research in our laboratory. The role of RANKL in mammary gland development and bone metastasis suggested that the identification of a RANKL-regulated stromal factor in breast tissue (bcaf-2) was not an artefact. RANKL is a membrane-bound, member of the tumour necrosis factor (TNF)-a cytokine super family. In order to test the hypothesis that RANKL might act as an inflammatory cytokine to regulate clinically significant stromal gene expression in the breast, we employed quantitative real time PCR analysis to examine the relative levels of selected members of a group of metal dependent ECPs, the matrix metalloproteinases (MMPs). RNA was extracted from ML cells and OCL cells, as well as RANK positive breast cancer cell lines (T47D, MDA-MB-435 & MCF-7). When the relative levels of protease mRNA were compared we demonstrated a significant (>20- fold) specific increase in collagenase (collagenase 2lMMP-8 and collagenase 3lMMP-13), and the tissue inhibitor of MMP (TIMP)-2 expression in M-CSF and RANKL treated PBMCs cells. When the assay was applied to RANKL treated breast cancer cell lines (MCF-7, T47D & MDAMB- 231), minor (40-fold) but potentially significant alterations in stromal protease gene expression were observed. The changes observed did not however, support the hypothesis that RANKL might act as an inflammatory cytokine to induce significant alterations in ECP expression in breast cancer cells. To investigate the role of RANKL as a driver of EMT in aberrant breast epithelium, total message (mRNNcDNA) from T47D, MCF-7, MDA-MB-231 cells, and message from the same cell lines treated with RANKL were compared by comparative fluorescent cDNA microarray analysis. Of the 1,700 targets available on the arrays, this study identified 160 that were differentially expressed in RANKL treated cells. The results suggest that RANKL may promote rather than suppress a mammary epithelial phenotype in breast cancer. In fact a putative mesenchymal to epithelial transition (MET) was observed following microscopic analysis, and this finding is the subject of on going research in our laboratory. Sporadic structural alterations in certain mitogenic factors represent important early events in cancer progression, while inherited mutations govern familial susceptibility to disease. In colon cancer, a close link exists between Winglessllnt (WNT) signalling, disease pathology, and the expression of MMPs. To examine the relationship between protease expression and structural genetic alterations in this EMT-linked signalling pathway, and others, we applied combined QPCR analysis of MMP expression and PCR-Single Strand Conformation Analysis (SSCA) to 26 colonic tumours, and patient-matched normal colonic mucosa. In this study, significant correlations between the expression of ECPs, and a key mediator of WNT signalling (p-catenin) were identified. While tumours possessing specific functional mutations in K-Ras, were found to group with phenotypic clustering based on protease gene expression. This result may be due to an interruption of normal interactions between RasIRaf signalling and transforming growth factor (TGF) P signalling, via Sma- and Mad- related protein (SMAD) signalling. These results demonstrate that the already identified link between mutations in kinase signalling, and aspects of gross colon tumour morphology (such as dysplasia) may be due to aberrant MMP expression patterning. The final aim of this research was to utilise methods developed in microdissection and specific Q-PCR analysis, to identify whether tumour-stroma differences in MMP gene expression might be used as markers of disease pathology. Total RNA from tumour, and biopsy-matched adjacent stromal tissue were segregated from 35 FFPE archival breast tumour biopsies. Comparison with stroma identified specific associations between TIMP-2 expression in the stroma and lymph node involvement, as well as stromelysin-3 (MMP-I I ) and TIMP-I expression and calcification of the tumour. Furthermore, a significant correlation was identified in the pattern of gelatinase (gelatinase AIMMP-2 & gelatinaseB1MMP-9) expression; while no significant correlation was identified in tumour-stroma MMP gene expression differences, and tumour grade, or hormone receptor status. These results suggest that coordinated changes within the tumour, and proximal stromal tissues (rather than tissue specific changes per se), regulate pathologically significant changes in breast carcinogenesis. In conclusion, this thesis describes the use of novel techniques in specific and global gene expression analysis that permitted examination of stromal gene expression changes in epithelial tumour progression. Microdissection facilitated localisation of expression to particular tissues, while cell culture models provided material with which to optimise and demonstrate the efficacy of techniques used (where tumour material itself was not abundant). Furthermore, we have identified significant and specific correlations between general stromal protease gene expression changes, a putative mammary epithelial differentiation factor (RANKL), alterations in growth factor signalling, and epithelial tumour pathology in the breast and colon. The combination of techniques developed in this study may assist in improvement of categorisation of tumours in clinical pathology. Specifically, the development of novel grading systems that link underlying molecular genetic changes with changes in tumour pathology. These processes may assist to improve diagnosis and provide more effective patient/tumour-specific drug therapies.

<p>Antisense oligonucleotides (ODN) may interfere in gene expression on the basis of hybridising to its complementary messenger RNA (mRNA) sequence in the cell thereby preventing the synthesis of the peptide. Therefore, these ODNs may be potential drugs to treat human diseases by “knocking down” the expression of responsible genes or correcting the maturation process of mRNA in the field called antisense therapy. Moreover, antisense ODNs upon labelling are also potential imaging agents to monitor gene expression <i>in vivo</i>, i.e. to accomplish <i>in vivo</i> hybridisation. This would provide a non-invasive tool compared to present methods, which require tissue samples. </p><p>This goal may be reached using positron emission tomography (PET) methodology. PET is a most advanced <i>in vivo</i> imaging technology, which would allow exploring the fate of radionuclide-labelled antisense ODNs in the body; thereby providing information about biodistribution and quantitative accumulation in tissues to assess pharmacokinetic properties of ODNs. This kind of evaluation is important as part of the characterisation of antisense therapeutics but also as part of the development of antisense imaging agents.</p><p>The present study aimed to investigate ⁷⁶Br- and ⁶⁸Ga-labelled ODNs of five different modifications: phosphodiester, phosphorothioate, 2'-<i>O</i>-methyl phosphodiester, locked nucleic acid (LNA), and peptide nucleic acid. The study included exploration of the hybridisation abilities of these ODNs after labelling; furthermore, the biodistribution, metabolite analysis and uptake of the ODNs in rats regarding non-hybridisation and hybridisation specific uptake was conducted. Among the ODNs studied, LNA-DNA mixmer (LNA and DNA nucleotides in alternation along the sequence) displayed the most promising characteristics considering a higher retention in tissues, stability and longer plasma residence. However, biodistribution data demonstrated a non-hybridisation specific distribution in rat tissues with kidney, liver, spleen and bone marrow being the organs of high uptake. Scavenger receptors or other saturable processes unrelated to hybridisation may play a role in tissue uptake and in clearance of antisense ODNs through these organs. These processes may be sequence dependent suggesting that proof of <i>in vivo</i> hybridisation through imaging needs much more elaborate evaluations than just comparison of sense and antisense sequences and proving dose-dependency.</p>

Antisense oligonucleotides (ODN) may interfere in gene expression on the basis of hybridising to its complementary messenger RNA (mRNA) sequence in the cell thereby preventing the synthesis of the peptide. Therefore, these ODNs may be potential drugs to treat human diseases by “knocking down” the expression of responsible genes or correcting the maturation process of mRNA in the field called antisense therapy. Moreover, antisense ODNs upon labelling are also potential imaging agents to monitor gene expression in vivo, i.e. to accomplish in vivo hybridisation. This would provide a non-invasive tool compared to present methods, which require tissue samples. This goal may be reached using positron emission tomography (PET) methodology. PET is a most advanced in vivo imaging technology, which would allow exploring the fate of radionuclide-labelled antisense ODNs in the body; thereby providing information about biodistribution and quantitative accumulation in tissues to assess pharmacokinetic properties of ODNs. This kind of evaluation is important as part of the characterisation of antisense therapeutics but also as part of the development of antisense imaging agents. The present study aimed to investigate 76Br- and 68Ga-labelled ODNs of five different modifications: phosphodiester, phosphorothioate, 2'-O-methyl phosphodiester, locked nucleic acid (LNA), and peptide nucleic acid. The study included exploration of the hybridisation abilities of these ODNs after labelling; furthermore, the biodistribution, metabolite analysis and uptake of the ODNs in rats regarding non-hybridisation and hybridisation specific uptake was conducted. Among the ODNs studied, LNA-DNA mixmer (LNA and DNA nucleotides in alternation along the sequence) displayed the most promising characteristics considering a higher retention in tissues, stability and longer plasma residence. However, biodistribution data demonstrated a non-hybridisation specific distribution in rat tissues with kidney, liver, spleen and bone marrow being the organs of high uptake. Scavenger receptors or other saturable processes unrelated to hybridisation may play a role in tissue uptake and in clearance of antisense ODNs through these organs. These processes may be sequence dependent suggesting that proof of in vivo hybridisation through imaging needs much more elaborate evaluations than just comparison of sense and antisense sequences and proving dose-dependency.

Hybrids are common, being found in about 25% of all plant species, but the isolating barriers which preserve species integrity are poorly studied. I investigated this question in the large New Zealand genus Celmisia Cass. (Asteraceae), which hybridises readily in cultivation, but wild hybrids are relatively rare. My study quantitatively tests four potential reproductive isolating barriers in 12 sympatric species of Celmisia found in the Craigieburn Range, inland Canterbury, New Zealand. I examined two potential prezygotic reproductive isolating barriers (flowering phenology and pollinator specialisation), and two potential postzygotic barriers (pre-dispersal seed predation and hybrid seed germination). I used null models to test whether Celmisia species had temporally segregated flowering times, and found that some Celmisia are temporally segregated and thus less likely to form hybrids. I used experimental pair-wise flowering arrays to observe insect visitation to six different Celmisia species pairs. While I found no difference in the overall pollinator community, several insect families showed preferences for some Celmisia species. Furthermore, I found that subtle floral character differences were driving these insect preferences. In particular, I found scape height to be positively associated with insect visitation with taller Celmisia being favoured over shorter species. Insect preferences did not translate into strong floral constancy, therefore indicating that Celmisia flower visitors are likely to be a weak barrier to hybridisation. I reared a range of insect seed predators from field-collected capitula of the hybrid C. x pseudolyallii and both parent species (C. lyallii and C. spectabilis). There was no overall difference in the number of seed-predators per capitulum between hybrid and parent Celmisia taxa. I collected and sowed seeds from three Celmisia hybrids and their parent species in order to test whether hybrids were less fertile than their parent species. I found no evidence to suggest that the seeds of hybrids had lower germination success than those of their parents. Overall I found evidence for only weak prezygotic reproductive isolation and no evidence for postzygotic isolation in the four barriers I examined in Celmisia.

Non-small cell lung carcinoma is a leading cause of cancer mortality worldwide. There are gender and smoking associated differences both in tumour types and clinical outcome. Squamous cell carcinomas (SCC) are more frequent among smoking men while females develop adenocarcinomas (ADCA). NSCLC among never smokers are mainly ADCA, and occurs mostly in females. The present thesis elucidates the role of estrogen receptor (ER) and epidermal growth factor receptor family (EGFR/HER2-4) in NSCLC in the perspective of gender and histology as well as the influence of smoking on those biomarkers. A recently developed technique, tissue micro array (TMA), was employed.The question of how much of a tumour tissue that needed to be included in a TMA for biomarker analysis was analyzed by a statistical approach. Data indicates a sample size of three cylinders of tumour tissue with a diameter of 0.6 mm each as being appropriate and cost-effective. In order to optimally use the up to thousands of different tumour samples within a TMA, it would be optimal to serially cut and store slides before performing in situ detection of proteins and nucleic acids. Applying up to date methodology, and by evaluation with image analysis, data are presented that shows that such handling of TMA slides would be possible without any loss of biomarker information. ERα is more frequently observed in ADCA and in females and a local estradiol synthesis is supported by the presence of aromatase. ERβ is identified as a positive prognostic marker in ADCA. Smoking is associated to increased levels of ERβ mRNA. EGFR over expression is associated with a ligand. Independent phosporylation of ERα. HER-4 intracellular domain may also act as a co-activator to ERα in ADCA, especially among neversmokers. The question of ER and EGFR family signalling crosstalk as a potential target for combined targeted therapy is raised.

No description available.

No description available.

Background: The blue mussel, Mytilus edulis L., is an important contributor to the shellfish sector of Scottish aquaculture, with 7,270 tonnes worth £8.8 million being produced for the year 2015. Since 2010, production values have fluctuated as a result of inconsistent spat settlement, several business closures, and heightened levels of marine toxins in some areas. On Scotland’s west coast, some farms (most notably Loch Etive) have suffered production losses from the appearance of non-marketable mussels with particularly fragile shells and poor quality meat. Recent research has demonstrated that these undesirable traits have a genetic factor, linked to the presence of a non-native but related species Mytilus trossulus (Gould, 1850) and often its hybrids with the native M. edulis. M. trossulus has been classed as a commercially damaging species under Scottish law, but there is insufficient data on hybridisation and introgression patterns in Scottish mussel populations to evaluate any possible impacts this could have on production. Existing research has focused on single locus genotyping to identify Mytilus spp. and their hybrids in Scotland. By instead utilising multilocus genotyping, introgression could be identified and a better understanding of population structure could be gained, with implications for management to maintain productivity and profitability. The aim of the research presented here was to develop and validate a suite of new species diagnostic markers for multilocus genotyping of field populations of Scottish mussels, thereby establishing a more complete picture of the taxonomic relationships between species than previous studies have permitted. Results: Analysis of SNPs identified with RADseq confirmed the presence of three genetically distinct Mytilus species in Scotland: M. edulis, M. galloprovincialis and M. trossulus. RADseq and KASP genotyping technology successfully identified and validated a suite of 12 highly robust diagnostic SNP markers for multilocus genotyping of Mytilus mussel populations. These markers permitted more comprehensive genotyping than previous studies had, allowing presumed pure species individuals to be distinguished from first generation (F1) hybrids and introgressed (FX) genotypes in reference populations, and subsequently presented the possibility of exploring introgression in a wider scale study. Multilocus genotyping of mussel populations from around Scotland revealed widespread introgression of M. edulis with both M. galloprovincialis and M. trossulus. No pure M. galloprovincialis was identified and pure M. trossulus was restricted to a single site in Loch Etive, possibly part of a relict population. F1 hybrids between M. edulis and M. trossulus were identified in Loch Etive and in Loch Fyne on the west coast. This was evidence of ongoing hybridisation and suggested an active hybrid zone existed in Scotland, something that previous single locus genotyping studies had not acknowledged. A link between shell fragility and M. trossulus introgression was recognised at a single site outside of Loch Etive, but this was not apparent anywhere else and the actual causes of shell fragility remain unevaluated. There was a clear difference between the genetics of most farmed stock and wild populations, which indicated an anthropogenic effect on introgression and subsequent species composition, and had implications for future farm site selection and broodstock sourcing. Temporal species composition in Loch Etive differed over a short time period, but high proportions of M. trossulus alleles were observable some 25 months after a major fallowing event had taken place. Pure M. trossulus was also identifiable, which was consistent with the presence of an established population of M. trossulus existing in this area. Conclusion: Multilocus genotyping has produced a more in depth picture of species diversity in Scottish mussel populations. SNP assays revealed widespread introgression between three genetically distinct species – M. edulis, M. galloprovincialis and M. trossulus – and furthermore recognised that, to date, single locus genotyping has overestimated the abundance of pure Mytilus mussels in Scottish waters. However, this hitherto unidentified genetic complexity does not appear disadvantageous to mussel production, despite the prevalence of M. trossulus introgression among farmed populations, and it is somewhat unlikely that genetics are the sole cause of undesirable shell characteristics among Mytilus spp. mussels.

Ancrée dans une pratique personnelle de la gravure s’associant à la photographie, la vidéo et l’installation, cette thèse en arts plastiques explore l’hybridation entre arts et sciences. Elle commence par une recherche des spécificités de la gravure pour construire un point de vue singulier sur les œuvres d’artistes travaillant entre arts et sciences quels que soient leurs médiums. La première partie questionne l’hybridation de la gravure et du numérique comme voie d’accès à la contemporanéité définie par Giorgio Agamben comme «en déphasage» avec son temps. Dans une deuxième partie, l’imagerie médicale et la photographie questionnent l’altérité animale. La recherche se poursuit par l’analyse d’œuvres de Nagi Noda, Wanda Wulz et Xavier Lucchesi qui amènent la question de la référence aux mythes dans le travail personnel. Enfin dans une troisième partie, la recherche théorique et le travail plastique achèvent leur hybridation. Les mythes de Méduse, Orphée ou Épiméthée deviennent le point de départ de créations entre arts et sciences où le processus de la gravure actualise les mythes par l’empreinte qu’elle laisse dans les photographies, les vidéos ou les installations qui mettent en scène des images médicales. Notre thèse est que la gravure constitue, à l’image des archées – organismes récemment découverts par les biologistes – une pratique vivante qui se retrouve là où on ne l’attend pas. L’hybridation dans notre pratique artistique rapproche les archées de l’archè, qui signifie proche de l’origine. / Rooted in my personal practice of engraving combined with photography, video and installation art, this plastic arts thesis explores the hybridisation of arts and science; starting with research into the specificities of engraving to then construct a singular point of view on the works of artists whose practice falls between arts and science, whatever the medium. The first part questions the hybridisation of engraving and digital techniques as an access route to a contemporaneity described by Giogio Agamben as “out of phase” with its time. In the second part, medical imagery and photography question animal alterity. Then the research will be furthered through the analysis of works by Nagi Noda, Wanda Wulz, and Xavier Lucchesi which bring us to the matter of references to myths in personal work. Lastly, in a third part, theoretical research and physical art practice complete their hybridisations. The myths of Medusa, Orpheus and Epimetheus become the starting point of works between art and science where the process of engraving actualises the myths by the imprints it leaves in photographs, videos or installations which show medical imagery. Our thesis is that engraving is, like the archaea – recently discovered microorganisms –, a living practise that can sometimes be found where one least expects it. The hybridisation of our practise bring archaea closer to the arche, and thus closer to the origin.